Vericel Revenue, Growth & Competitor Profile

DBA AASTROM BIOSCIENCES INC

Company Profile & Annual Report for Vericel

Access the complete profile.

Vericel Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	64 Sidney St Cambridge, MA 02139

Note: Revenues for privately held companies are statistical evaluations.


Vericel's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Vericel's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Vericel is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Vericel Annual Revenue and Growth Rate

Vericel	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vericel's revenues are gauged from an analysis of company filings.

Vericel's Income Statement (based on Industry Averages)

Vericel P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Vericel is developing and marketing. Vericel doesn't have any recent trademark applications, indicating Vericel is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ULU Pharmaceutical preparations for the treatment of articular cartilage disease	04/10/2017
MYCARTILAGECARE Pharmaceuticals for the treatment of articular cartilage disease; human cells for medical purposes; cultured human cells for therapeutic use	12/28/2015
MYCI Pharmaceutical preparations for the treatment of articular cartilage disease	11/30/2015

See all trademarks and details in the Full Report.

Market Share of Vericel's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vericel, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Vericel. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
HAEMONETICS	125 Summer Street, MA	100
VERICEL	Cambridge, MA	29
KIC MANAGEMENT GROUP	Malden, MA	27
DROPLETTE	Boston, MA	9
MYOMO	Boston, MA	8
Q-STATE HOLDINGS	Cambridge, MA	5

Future Competition: Vericel's Fastest Growing Competitors

These companies are in the same general field as Vericel and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)